Endo International Plc
(NASDAQ : ENDP)

( )
ENDP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
0.06%176.410.4%$129.75m
PRGOPerrigo Co. Plc
-1.53%72.566.8%$98.05m
MNKMallinckrodt Plc
-2.62%29.7021.1%$71.66m
JAZZJazz Pharmaceuticals Plc
-1.14%159.172.2%$69.03m
ENDPEndo International Plc
-0.25%15.858.9%$59.65m
PTLAPortola Pharmaceuticals, Inc.
-3.30%28.407.7%$40.55m
UTHRUnited Therapeutics Corporation
1.63%125.9414.4%$39.16m
SAGESAGE Therapeutics, Inc.
0.26%145.519.6%$36.92m
CTLTCatalent Inc
0.96%43.002.4%$36.86m
ICPTIntercept Pharmaceuticals, Inc.
-1.24%117.3018.7%$30.73m
ZGNXZogenix, Inc.
-0.62%48.5011.9%$29.86m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-0.17%140.946.8%$29.26m
SUPNSupernus Pharmaceuticals, Inc.
-4.27%46.006.2%$27.18m
MDCOMedicines Company
-1.47%33.5621.8%$25.01m
ICLRICON Plc
-1.65%145.274.2%$23.83m

Company Profile

Endo International Plc operates as a pharmaceutical company. It focuses on developing, manufacturing, and distributing of branded and generic pharmaceutical products. The company operates through the following segments: U.S. Branded Pharmaceuticals, U.S. Generic pharmaceuticals and International Pharmaceuticals. The U.S. Branded Pharmaceuticals offers products that focus on the treatment and management of conditions in urology, urologic oncology, endocrinology, and orthopedics. The U.S. Generic pharmaceuticals segment consist of a differentiated product portfolio including high-barrier-to-entry products, first-to-file or first-to-market opportunities that are difficult to formulate, difficult to manufacture or face complex legal and regulatory challenges. The International Pharmaceuticals segment includes a variety of pharmaceutical products for the Canadian, Latin American, South African, and world markets. Endo International was founded in 1997 and is headquartered Dublin, Ireland.